A nurse is assessing a 28-year-old male patient who has been receiving haloperidol for acute psychosis for 48 hours. Which assessment finding would be the MOST concerning and require immediate intervention?

Haloperidol, a first-generation antipsychotic (dopamine D2 receptor antagonist), is used to manage acute psychosis. While effective, it carries a risk of extrapyramidal symptoms (EPS) and a rare but life-threatening adverse reaction called neuroleptic malignant syndrome (NMS). The nurse must differentiate between expected side effects, distressing but non-lethal reactions, and a medical emergency requiring immediate intervention.

The most concerning finding is Option 3: a temperature of 104°F (40°C), muscle rigidity, and altered mental status. This triad is the hallmark of neuroleptic malignant syndrome (NMS), a potentially fatal condition associated with dopamine antagonist use, including haloperidol ^[2]. The hyperthermia and rigidity in NMS stem from dopamine receptor blockade in the hypothalamus (impaired thermoregulation) and basal ganglia (severe muscle rigidity), which can lead to rhabdomyolysis, acute renal failure, and death if not promptly recognized and treated ^[1]. The onset can occur within 24 to 72 hours of drug initiation, making this timeline critical for assessment ^[2].

The other options represent known adverse effects of haloperidol but do not constitute an immediate, life-threatening emergency:

• Option 1: Mild tremor and shuffling gait are classic extrapyramidal symptoms (EPS), specifically parkinsonism, caused by dopamine D2 receptor blockade in the nigrostriatal pathway. These are dose-related and managed with dose reduction or anticholinergic medication, not a reason for emergency intervention.


• Option 2: Dry mouth and blurred vision are anticholinergic side effects from haloperidol's action on muscarinic receptors. While uncomfortable, they are not life-threatening.


• Option 4: Restlessness and inability to sit still describe akathisia, a distressing form of EPS. It requires recognition and management but does not pose an immediate threat to physiological stability like NMS does.

The diagnostic challenge in NMS lies in its overlap with other hyperthermic syndromes, such as serotonin syndrome, especially in patients on multiple psychotropic medications ^[1][2]. The key differentiator here is the recent initiation of a potent D2 antagonist (haloperidol) and the classic triad of hyperthermia, generalized "lead-pipe" rigidity, and altered mental status. The severe muscle rigidity is the primary source of the extreme hyperthermia, creating a dangerous feedback loop of cell damage and metabolic acidosis. Immediate nursing intervention involves stopping the offending agent, initiating supportive care (cooling measures, hydration), and preparing for potential transfer to a higher level of care, as NMS carries significant mortality if unrecognized ^[2].